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Commentary
Air pollution epidemiology plays an integral 
role in both identifying the hazards of air 
pollution to human health and informing 
the design and implementation of air quality 
policy (Greenbaum et al. 2001). A large and 
growing body of epidemiological studies has 
helped characterize for policy makers the link 
between ambient air pollution and the risk 
of an array of adverse health outcomes. In 
particular, those studies that have observed a 
relationship between both long-term expo-
sure to particulate matter ≤ 2.5 μm in aero-
dynamic diameter (PM2.5) and premature 
death and between short-term ozone exposure 
and morbidity impacts have provided key 
empirical evidence in support of air quality 
standards (Ito 2003; Pope et al. 2002). The 
findings of these and other epidemiological 
studies have informed critical policy deci-
sions regarding the appropriate levels of the 
National Ambient Air Quality Standards for 
the six common “criteria pollutants” in the 
United States [U.S. Environmental Protection 
Agency (EPA) 2007b] and the levels of the 
World Health Organization (WHO) air qual-
ity guidelines (WHO 2005) in Europe.
No less important, but perhaps not as 
broadly recognized, is the role of air pollution 
epidemiology in supporting quantitative risk 
assessments—principally by providing the 
risk coefficients that relate air quality changes 
to the probability of a variety of adverse 
health outcomes, including premature death, 
hospital visits, and acute respiratory symp-
toms, among many others. In general, risk 
assessments aim to answer one of two types of 
policy questions. First, what is the total pub-
lic health burden associated with exposure to 
air quality levels above some background level 
in terms of the number of excess cases of pre-
mature death or illness? Examples of this type 
of analysis include a report by Cohen et al. 
(2004) that quantified about 800,000 pre-
mature PM2.5-related deaths per year in urban 
areas globally and a global burden assessment 
by Anenberg et al. (2010) that estimated 
approximately 4.2 million premature deaths 
per year attributable to anthropogenic PM2.5 
and ozone. A second and related question is, 
what would be the impact on human health 
of incremental changes in air quality due to 
a proposed policy? As an example, the U.S. 
EPA assessment of the benefits of the Clean 
Air Act Amendments of 1990 [Clean Air Act 
Amendments 1990; §109(b)(1)] estimated 
approximately 230,000 PM2.5 and ozone-
related premature deaths were avoided begin-
ning in 2020 due to the implementation of 
the Clean Air Act Amendments (U.S. EPA 
2011). In Europe, a WHO analysis of trans-
boundary air pollution found that a climate 
policy incorporating “maximally technically 
feasible reductions” could reduce the   number 
of ozone-related deaths by approximately 
8,000 per year (WHO 2008).
These types of quantitative risk assessments 
are frequently performed in a cost–benefit 
framework where the health impact estimates 
expressed as an economic value can be sub-
stantial (U.S. EPA 2010). The risk assessment 
accompanying a recent rule affecting coal-
burning electrical-generating units used risk 
coefficients drawn from two long-term mor-
tality studies based on the American Cancer 
Society and Harvard Six Cities cohorts (Laden 
et al. 2006; Pope et al. 2002) to estimate a 
change in PM2.5-related premature mortality 
of 14,000 and 36,000; the analysis estimated 
the economic value of these and other health 
and welfare benefits to be between $120 to 
$270 billion U.S. dollars (3% discount rate, 
2006 dollars) (U.S. EPA 2010). In many 
cases, the findings of these risk and benefits 
assessments are broadly cited by the media 
and used by policy makers to justify signifi-
cant changes in air quality policy (New York 
Times 2010; U.S. Congress 2010).
Air pollution epidemiology and quantita-
tive risk assessment are sometimes thought to 
be distinct disciplines with slightly different 
aims—epidemiology being concerned with 
hypothesis testing and hazard identification 
and risk assessment with adapting these find-
ings to answer policy questions. This com-
mentary contends that these two disciplines in 
fact share a number of interests and that much 
can be gained by their tighter integration. 
Perhaps the most obvious of these interests 
is a common desire to ensure that the results 
of epidemiological studies are used appropri-
ately in risk assessments [Hubbell et al. 2009; 
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Ba c k g r o u n d: Air pollution epidemiology plays an integral role in both identifying the hazards of 
air pollution as well as supplying the risk coefficients that are used in quantitative risk assessments. 
Evidence from both epidemiology and risk assessments has historically supported critical environ-
mental policy decisions. The extent to which risk assessors can properly specify a quantitative risk 
assessment and characterize key sources of uncertainty depends in part on the availability, and clar-
ity, of data and assumptions in the epidemiological studies.
oBjectives: We discuss the interests shared by air pollution epidemiology and risk assessment com-
munities in ensuring that the findings of epidemiological studies are appropriately characterized and 
applied correctly in risk assessments. We highlight the key input parameters for risk assessments 
and consider how modest changes in the characterization of these data might enable more accurate 
risk assessments that better represent the findings of epidemiological studies.
discussion: We argue that more complete information regarding the methodological choices and 
input data used in epidemiological studies would support more accurate risk assessments—to the 
benefit of both disciplines. In particular, we suggest including additional details regarding air qual-
ity, demographic, and health data, as well as certain types of data-rich graphics.
co n c l u s i o n s: Relatively modest changes to the data reported in epidemiological studies will 
improve the quality of risk assessments and help prevent the misinterpretation and mischarac-
terization of the results of epidemiological studies. Such changes may also benefit epidemiologists 
undertaking meta-analyses. We suggest workshops as a way to improve the dialogue between the 
two communities.
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NARSTO (formerly North American Research 
Strategy for Tropospheric Ozone) 2010]. 
Although risk assessors seek to use the best 
available data in their analyses, epi  de  miologists 
wish for their data not to be misused and their 
findings not to be mi  sinterpreted. An exten-
sive history of scientists and institutions offers 
guidance on how this relationship should 
work—how epidemiological data might be 
used responsibly and effectively in air pollution 
risk assessment (National Research Council 
1985, 1990, 1997, 2002, 2008; Neutra et al. 
2006; WHO 2000). We add to this literature 
by suggesting a series of modest changes to the 
presentation of the data and to the findings of 
epidemiological studies that will encourage the 
accurate use of this information in quantitative 
risk assessments and, at the same time, benefit 
those epidemiologists who undertake meta-
analyses. We also suggest that an improved 
dialogue between these two communities 
might highlight areas for future research rele-
vant to both communities.
Using the Findings from 
Epidemiology Studies in 
Quantitative Risk Assessments
Risk assessments generally apply a health 
impact function combining a) risk estimates 
from the epidemiology literature that relate air 
quality changes and health outcomes, b) mod-
eled or observed air quality changes to charac-
terize exposure, c) the population at risk, and 
d) baseline health status (prevalence and inci-
dence of disease) of that population. For the 
key data necessary to specify this health impact 
function, analysts look to epidemiologi-
cal studies for a quantitative meas  ure (often 
referred to as an “effect estimate”) relating 
changes in air quality to changes in health risk.
As noted above, there is an extensive 
body of literature that broadly describes the 
appropriate use of epidemiological evidence 
in health risk assessment. Among the most 
important considerations are a) accounting for 
differences in the demographic profile and air 
pollution exposure of the evidentiary and tar-
get populations, b) avoiding double counting 
of impacts, and c) characterizing the sensitivity 
of the results to key input parameters. Many 
(although by no means all) of the uncertain-
ties inherent in risk assessments are influenced 
greatly by the methodological choices of the 
epidemiological study—which the risk assess-
ment should account for, or at least acknowl-
edge, to the extent possible with the reported 
data. However, obtaining the necessary infor-
mation from published epidemiological stud-
ies to fulfill these guidelines is sometimes 
challenging. In many cases, study authors may 
not consider these data to be central to the 
hypothesis being tested and so will choose not 
to report this information—perhaps not realiz-
ing how these data might contribute to a more 
appropriate use of the study findings. Below 
we discuss the aspects of epidemiological stud-
ies that, although not always reported, are 
important to well-designed risk assessments. 
We also describe instances in which the data 
reported in epidemiological studies directly 
influenced the design of health impact analy-
ses and subsequent policy decisions.
Key attributes of epidemiological studies 
relevant to risk assessments. Effect estimates. 
Among the first steps in the risk assessment 
is properly accounting for the model speci-
fication of the epidemiological study within 
the health impact function. Although the use 
of Poisson or logistic regression in a study is 
generally very clear and easily accounted for in 
the health impact function, there are a variety 
of other data useful to the risk assessor that, 
although perhaps not readily accessible, are 
important to the quantification and charac-
terization of impacts. For example, many 
epidemiological studies conduct analyses of 
the sensitivity of risk coefficients to alternate 
model specifications, which can also provide 
extremely valuable insights for risk assess-
ments and meta-analyses, although research-
ers may not fully describe this information. 
Such sensitivity analyses might include adjust-
ment for confounders (e.g., other pollutants) 
or effect modifiers (e.g., demographic vari-
ables), information that can be incorporated 
into risk assessments. More routine numerical 
presentation of uncertainty for risk coefficients 
and other variables (e.g., t-statistics, p-value, 
95% confidence interval, standard error of 
central estimates) would also be useful to risk 
assessments. Where studies consider the com-
bined (or synergistic and antagonistic) impacts 
of exposures to two or more pollutants, or 
temperature and one or more pollutants, a 
variance–covariance matrix can allow the risk 
assessor to quantify confidence intervals from 
a joint uncertainty distribution. Finally, null 
or not statistically significant results, although 
less likely to be published, may still prove use-
ful to those performing risk assessments and 
meta-analyses and warrant closer attention 
than they currently receive.
Although it is generally true that those 
performing either risk assessments or meta-
analyses would prefer more detailed informa-
tion regarding key data and assumptions, the 
study author’s choice of how to present this 
information can greatly influence its interpret-
ability to different audiences. In many cases, 
the presentation of risk estimates in a com-
prehensive table (for example, see Bell and 
Dominici 2008, their Table 5) that account 
for alternate model specifications and effect 
modifiers will provide the details necessary to 
inform a risk assessment. However, data-rich 
graphics can complement the presentation of 
certain tabular data and yield unique insights. 
For example, the U.S. EPA recently evaluated 
the long-term PM–mortality literature to con-
sider the empirical basis for a threshold in the 
concentration–response relationship. The U.S. 
EPA found useful the graphics depicting the 
concentration–response curve and 95th per-
centile confidence interval over the range of 
the observed data [for example, see Figure 1 
(Schwartz et al. 2008)]. These illustrations 
demonstrated the relationship between the 
width of the confidence intervals around the 
mean estimate at various air quality levels and 
the density of the observed air quality data—
helping the U.S. EPA to evaluate the plau-
sibility of a concentration threshold in the 
PM–mortality relationship.
Air quality. A major analytical challenge 
facing risk assessments is ensuring that their 
treatment of modeled or observed air qual-
ity changes or exposure estimates is compat-
ible with the treatment of air quality in the 
epidemiological study. This can relate to the 
composition and relative levels of pollution 
mixtures over space and time, methods used 
to estimate exposure, or the characterization 
of pollutant exposures. An example is the 
air quality metric used to assess short-term 
ozone-related premature mortality. In its 2008 
assessment, the U.S. EPA relied on a national 
time-series study and three meta-analytic stud-
ies (Bell et al. 2004, 2005; Ito et al. 2005; 
Levy et al. 2005). Each study related mortal-
ity risk to a 10-ppb change in one or more 
ozone metrics, including the 24-hr mean, 
the 1-hr daily maximum, and the 8-hr daily 
maximum. Consequently, when performing 
its risk assessment, the U.S. EPA converted 
each risk coefficient based on a 24-hr mean or 
a 1-hr maximum into one based on an 8-hr 
maximum, assuming a constant ratio between 
each pair of metrics (U.S. EPA 2007a). This 
process introduces uncertainty to the analysis 
(Anderson and Bell 2010). Although the avail-
ability of air quality data affected the selection 
of metrics in each study, presentation of results 
from multiple metrics would have mitigated 
this uncertainty for both risk assessors as well 
as those performing meta-analyses.
Likewise, PM2.5 composition varies across 
locations and seasons and may affect its toxic-
ity. Recent literature suggests that some chemi-
cal components and sources may have stronger 
effects than others and that differences in effect 
estimates across cities or seasons may relate to 
the chemical composition of particles (Bell 
et al. 2009; Franklin et al. 2007; Laden et al. 
2000; Lippmann et al. 2006; Peng et al. 2009; 
Zanobetti et al. 2009). Presentation of infor-
mation regarding the chemical speciation of 
PM2.5 mass, if available, is thereby valuable 
to risk assessments in the characterization, if 
not quantification, of results. This informa-
tion could permit assessors to down- or up-
weight results (qualitatively or quantitatively) 
based on differences (or similarities) in the Linking epidemiology with risk assessment
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particle composition between the target and 
  evidentiary populations.
Risk assessments rarely have the oppor-
tunity to rely on risk coefficients from epide-
miological studies in which the temporal and 
spatial variability in air quality is fully consis-
tent with that of the policy scenarios being ana-
lyzed. For example, risk assessments frequently 
apply projected air quality values, sometimes 
resulting in a spatial distribution and temporal 
pattern of air pollution that diverges consider-
ably from the epidemiological study; this is an 
especially important issue for risk assessments 
transferring risk coefficients from one region 
of the world to another, where temporal and   
spatial patterns may be significantly different.
Certain analytical choices have a particu-
larly strong influence on the temporal and spa-
tial distribution of air quality values observed 
in epidemiological studies. For example, epi-
demiology studies frequently use a central site 
monitor to represent air quality for a given 
area or an agglomeration of monitors across a 
city. Often studies note the number of moni-
tors and source of data but provide little other 
information because researchers may not con-
sider it central to the hypothesis being studied, 
although information regarding such monitors 
(e.g., location and method of measurement) is 
useful to understanding how risk estimates for 
that urban area may be influenced by particu-
lar sources such as roadways or industrial facil-
ities. The number, location, and measurement 
(i.e., instrument) error of monitors are also 
important for interpreting uncertainty in expo-
sure estimates because of spatial and temporal 
heterogeneity of pollutant concentrations—as 
is information regarding treatment of missing 
values, exceptional events, and flagged data 
in estimating exposure (Goldman et al. 2010; 
Peng and Bell 2010).
Community-level variables, including   
temperature and air conditioning prevalence, 
can modify air pollution health risks and there-
fore may explain differences in the relation-
ship between pollution levels and the health 
responses between study populations. For 
example, cities with higher air conditioning 
prevalence tend to have smaller effect estimates 
for ozone and PM2.5 (Franklin et al. 2007; 
Levy et al. 2005). These and other effect modi-
fiers can be considered formally within risk 
assessments or meta-analyses, provided that 
epidemiological studies characterize the impact 
of these variables and note their origin.
Population. Epidemiologic studies gener-
ally relate historical changes in observed air 
quality with a change in health risk among 
a particular population in specific locations. 
Conversely, risk assessments tend to estimate 
the incidence of adverse health outcomes 
among a population whose attributes are some-
times very different from the study popula-
tion in ways that may alter the outcome of 
the risk assessment. Furthermore, risk assess-
ments often model health impacts of air quality 
changes over the long term (U.S. EPA 2010), 
requiring them to project into the future the 
population’s size, geographic distribution, and 
demographic profile. For each of these reasons, 
detailed information regarding population age, 
sex, race, ethnicity, socioeconomic conditions 
(e.g., income, education), and spatial distribu-
tion—and how the study authors may have 
used these variables to adjust the risk coeffi-
cients—are each important considerations for 
the risk assessment. This same information is 
essential to risk assessments and meta-analyses 
because they pool results across epidemiological 
studies that consider populations of differing 
age ranges, sex, or races. Similarly, as alluded to 
above, although epidemiological studies some-
times adjust risk coefficients according to the 
key demographic (e.g., age, sex, race) or socio-
economic attributes (e.g., income, education), 
these results are not always presented within 
the paper or supplementary materials.
Health data. Detailed characterization of 
the health data used in epidemiologic studies is 
very important to risk assessors as they consider 
which end points to quantify, how to match 
key characteristics of the end points across 
populations, and how and whether to pool 
evidence across studies. Study authors may 
select International Classification of Diseases 9th 
Revision (ICD-9; WHO 1977) or 10th Revision 
(ICD-10; WHO 1999) codes for a variety of 
reasons such as data availability and signifi-
cance of findings, among others. Although this 
aspect of the study is not always well docu-
mented, it is very important to risk assessors 
as they consider which end points to quantify 
and how and whether to pool evidence across 
studies in risk assessments and meta-analyses; 
these points are particularly important for risk 
assessments that transfer effect estimates from 
one region to another.
In some cases, ICD codes can be inferred, 
but in other cases, the same descriptive end 
points can span a range of codes. Further, not 
all researchers define disease categories (e.g., 
“pneumonia”) with identical ICD categories, 
hindering comparison and synthesis across 
results in risk assessments or meta-analyses (Ji 
et al. 2011). As another example, although one 
study may estimate the change in respiratory 
hospital admissions (ICD-9 codes 460–519), 
another may include hospitalizations for respi-
ratory illness (ICD-9 codes 490–492, 464–466, 
480–487) (Peng et al. 2009). In some cases, it is 
unclear whether the selected ICD codes are an 
artifact of the available data or limited statisti-
cal power or a deliberate and hypothesis-driven 
decision. In other cases, the study may not indi-
cate the entity that provided baseline health 
data, which prevents an exact replication.
Figure 1. The estimated concentration–response relationship between PM2.5 and the risk of death in the 
Harvard Six Cities Study, using a penalized spline with 18 knots (solid circles) and pointwise 95% confi-
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Risk assessments would also benefit from 
a more detailed specification in the epide-
miological study of key attributes of baseline 
health data, including whether 
Death or admission was based on primary  •	
or secondary causes.
Scheduled or unscheduled hospital visits  •	
were used.
Ultimate discharges from the hospital or  •	
emergency department were fatal or non  fatal. 
The emergency department visit resulted in  •	
admittance to the hospital. 
The hospital or emergency department visit  •	
was one of many visits in a multiday period.
Baseline rates were age •	  adjusted. 
Baseline mortality or hospital discharge rates  •	
were spatially aggregated.
Baseline incidence rates were interpolated  •	
for locations with missing data. 
Prior analyses suggest the importance of 
applying baseline health data that are appro-
priately matched to the effect coefficients used 
in the analysis (Hubbell et al. 2009; Wesson 
et al. 2010). Reporting summary statistics of 
health data used in epidemiological studies 
would also reduce uncertainties associated 
with matching these data in risk assessments 
or meta-analyses. Clearly, it will not always 
be possible for study authors to generate data 
of such detail, but generally risk assessors will 
benefit from more specific information.
Encouraging Dialogue between 
Air Pollution Epidemiology and 
Risk Assessment
Laying out the key challenges in using risk esti-
mates from epidemiological studies for risk 
assessments is only a tentative first step toward 
resolving them. An ongoing dialogue between 
the risk assessment and epidemiology commu-
nities is necessary both to illuminate the shared 
interests and needs of each community and to 
ensure that epidemiological findings are used 
appropriately. As risk assessments increase in 
complexity by considering multipollutant and 
temperature–pollutant interactions and mul-
tiple PM components and sources, the impor-
tance of this dialogue and of mechanisms to 
share critical information from epidemiological 
studies is even greater.
A few mechanisms already exist to facili-
tate better data sharing between epidemiolo-
gists and analysts conducting health risk 
assessments supporting regulatory analyses. 
For example, online supplements, which are 
accessible at either a journal or an author-
specified website, can make available data, 
sensitivity analyses, and detailed methods that 
are important both to epidemiologists and 
to risk assessors. Placing detailed informa-
tion in a supplement to the article ensures 
that risk assessors and epidemiologists can 
access key data without overwhelming readers 
less interested in such information; because 
some journals limit the size of supplementary 
materials, authors may wish to communicate 
the benefits of this information to editors. 
The International Society for Environmental 
Epidemiology published guidelines articu-
lating the responsibilities of original investi-
gators and those who undertake reanalyses 
or reinterpretation of critical epidemiologi-
cal studies (Neutra et al. 2006). Likewise, a 
national database of risk assessments might 
also provide risk assessors with examples of 
best practices. Effective use of these tools 
would serve epidemiology, risk assessments, 
and, by extension, public health—while bal-
ancing the rights of the public and the intel-
lectual property rights of investigators.
Although the greater availability of data 
and risk assessments holds great promise, 
such an approach would need to be weighed 
against the potential for these data to be mis-
interpreted or willfully misused. For these or 
any other mechanisms to be of practical use 
to either epidemiologists or risk assessors, an 
ongoing dialogue is needed between the two 
communities. Such a dialogue should iden-
tify the core research questions important to 
both communities—while fostering the most 
accurate risk assessments and discouraging 
the unintentional misuse of epidemiological 
findings. One way to initiate this dialogue 
would be to develop a series of U.S. EPA-
sponsored or HEI-sponsored case studies or 
Appendix 1.
Below we summarize the information regarding the specification of effect estimates, air 
  quality, populations, and baseline health data that we described above as being most helpful 
to risk assessors and epidemiologists conducting meta-analyses. This list is neither exhaus-
tive nor intended to serve as criteria for data-reporting requirements. However, authors and 
editors may find this summary useful as they consider how to make information reported in 
epidemiological studies more accessible to other practitioners.
Effect estimates
What type of statistical model was used? •	
Were sensitivity analyses performed? If so, did such analyses consider •	
Confounders, such as other pollutants?   –
Effect modifiers, such as demographic variables?   –
Were numerical data presented in sufficient detail, including •	
t   – -Statistics?
p   – -Values?
95% confidence intervals?   –
Standard error of central estimates?   –
Did the study consider combined effects? If so, was a variance– •	 covariance matrix included?
If null or statistically insignificant results were generated, were they reported? •	
Air quality
If ozone-related risk  •	 was estimated, did the study use alternate exposure metrics?
If PM-related risk was estimated, did the study summarize the particle composition? •	
If the study used air-quality monitor data, were the number, locations, and methods of  •	
measurement of such monitors reported?
Were community-level variables reported, including •	
Air conditioning prevalence?   –
Temperature?   –
Population
Were key population characteristics reported, including age, race, sex, ethnicity, and socio- •	
economic status?
What is the spatial distribution of the population considered? •	
Health data
For each health end  •	 point assessed, what corresponding ICD-9 or ICD-10 codes were used?
What criteria were considered when selecting ICD codes? •	
For the baseline health data applied: •	
Was the cause of admission or   –  death based on primary or secondary causes?
Were hospital visits scheduled or unscheduled?   –
Were hospital discharges fatal or non  fatal?   –
Did the emergency department visit result in a hospital visit?   –
Was the emergency department or hospital visit one among many in a multiday period?   –
Were mortality, hospital, and emergency department visit rates age-adjusted?   –
Were baseline mortality rates spatially aggregated?   –
Were baseline rates interpolated?   –Linking epidemiology with risk assessment
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workshops with a goal of making clear distinc-
tions between data or results that are likely 
already to exist but are not made readily avail-
able to health risk assessors, and those that 
may be lacking for a risk assessment because 
the underlying epidemiologic studies focused 
on different questions. The sometimes diver-
gent aims of epidemiology and risk assess-
ment should not preclude close collaboration 
between the disciplines—our scientific goals 
are not so far apart, and both communities 
stand to benefit.
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